Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-26 @ 2:08 AM
NCT ID: NCT00119405
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT00119405
Study Brief: Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ARV Naive ARV naive (have never been on antiretrovirals before) None None 2 18 12 18 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pancreatitis (Grade 3) None Endocrine disorders None View
Right Lower Lobe (RLL) Pneumonia (Grade 3) None Respiratory, thoracic and mediastinal disorders None View
Hypokalemia (Grade 2) None Metabolism and nutrition disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Incisional Hematoma (Grade 1) None Skin and subcutaneous tissue disorders None View
Low glucose 34 (Grade 3) None Metabolism and nutrition disorders None View
Low glucose 48 (Grade 2) None Metabolism and nutrition disorders None View
Tachycardia (Grade 2) None Cardiac disorders None View
Bone Mineral Density (BMD)/T scores -2.3 and -3.2 None Musculoskeletal and connective tissue disorders None View
Elevated creatine kinase (CK) levels (Grades 3 and 4) None Musculoskeletal and connective tissue disorders None View
Elevated alanine aminotransferase (ALT) 207 (Grade 2) None Hepatobiliary disorders None View
Elevated low-density lipoprotein (LDL) 175 (Grade 2) None Metabolism and nutrition disorders None View
Low absolute neutrophil count (ANC) (Grades 2 and 3) None Blood and lymphatic system disorders None View
Low white blood cell (WBC) count (Grade 2) None Blood and lymphatic system disorders None View
Incisional Seroma None Skin and subcutaneous tissue disorders None View
Infected Incisional Hematoma (Grade 2) None Skin and subcutaneous tissue disorders None View
Rash None Skin and subcutaneous tissue disorders None View
Elevated Aspartate aminotransferase (AST) (Grades 2 and 3) None Hepatobiliary disorders None View
Elevated Cholesterol 257 (Grade 2) None Metabolism and nutrition disorders None View